CVM Competitors & Alternatives

Compare CEL-SCI Corp with similar stocks in the same industry

Biotechnology

CVM

Main Stock
$1.91
+14.76%
Tradestie Score
42
Market Cap
$68.41M
Revenue Growth
-62.7%
Analyst Upside
+556.2%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Cancer Immunotherapy
Competitive Moat: None
Core Technology Stack: LEAPS platform, Multikine
Major Customers 2
Clinical trial sites Future oncology patients
Critical Suppliers 2
CROs API manufacturers
Direct Ecosystem Rivals 3

Top Competitors

220 stocks in Biotechnology
Company Price Market Cap P/E Score Action
OBIO Orchestra BioMed Holdings, Inc. Ordinary Shares
$7.02
-1.40%
$137.59M - 37 Compare
CLYM Climb Bio, Inc. Common Stock
$9.64
-3.02%
$133.50M - 45 Compare
AGEN Agenus Inc.
$6.13
-2.62%
$124.27M 29.3 47 Compare
SRZN Surrozen, Inc. Common
$29.94
-7.38%
$117.07M - 33 Compare
ANRO Alto Neuroscience Inc.
$25.12
-7.37%
$110.20M - 34 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.01
-0.33%
$84.52M - 53 Compare
IMMX Immix Biopharma, Inc. Common Stock
$7.23
-3.34%
$67.94M - 52 Compare
CRIS Curis Inc
$0.51
+18.10%
$20.87M 0.3 36 Compare
BGMSP BGMSP
$1.44
-39.75%
- - 50 Compare
CASIF CASIF
- - - - Compare

Data updated: Nov 17, 2026 | Industry: Biotechnology (SIC 2836)

220 stocks in this industry